Table: Brightpath Biotherapeutics -2019/20 parent results

BrightPath Biotherapeutics Co

15/05/2020 07:00

May 15 (Reuters)- 
          Brightpath Biotherapeutics Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2020    Mar 31, 2019    Mar 31, 2021      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          11 mln          155 mln          3 mln                  
               (-92.7 pct)     (-56.0 pct)     (-73.5 pct)               
  Operating     loss 1.83       loss 1.67       loss 1.89                
  Recurring     loss 1.82       loss 1.68       loss 1.89                
  Net           loss 1.86       loss 1.88       loss 1.91                
  EPS        loss 44.20 yen  loss 44.95 yen  loss 45.30 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T